Literature DB >> 20032330

Anthracycline dose intensification in acute myeloid leukemia.

Harris V K Naina, Mrinal M Patnaik, Samar Harris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20032330     DOI: 10.1056/NEJMc0910366

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Comparative efficacy and safety of eleven induction chemotherapy regimens for young adult patients with newly diagnosed acute myeloid leukemia: a network meta-analysis.

Authors:  Yiqing Li; Ting Tang; Jie Xiao; Boqi Li; Wenjuan Yang; Shuangfeng Xie; Yumo Du; Kezhi Huang; Danian Nie
Journal:  Ann Hematol       Date:  2022-04-20       Impact factor: 3.673

2.  One-Chip Isolation of Drug-Resistant Acute Myeloid Leukemia Cells with CXCR4-Targeted Magnetic Fluorescent Nanoprobes.

Authors:  Fan Wang; Yuqi Jiang; Luhai Wang; Yi Chen; Yu Zhang; Ming Ma
Journal:  Nanomaterials (Basel)       Date:  2022-05-17       Impact factor: 5.719

3.  HAG (Homoharringtonine, Cytarabine, G-CSF) Regimen for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis with 2,314 Participants.

Authors:  Mixue Xie; Qi Jiang; Li Li; Jingjing Zhu; Lixia Zhu; Yanlong Zheng; Xiudi Yang; Mingyu Zhu; Jianai Sun; Wanzhuo Xie; Xiujin Ye
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

Review 4.  Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges.

Authors:  Synat Kang; Yisheng Li; Jingqiao Qiao; Xiangyu Meng; Ziqian He; Xuefeng Gao; Li Yu
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.